Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
APO-METOPROLOL (TYPE L) APOTEX INC Actual shortage 100MG Updated Report 2024-05-24 227068
APO-ALFUZOSIN APOTEX INC Actual shortage 10MG Updated Report 2024-05-24 225779
APO-METFORMIN ER APOTEX INC Actual shortage 500MG Updated Report 2024-05-24 225770
APO-CEPHALEX APOTEX INC Actual shortage 500MG Updated Report 2024-05-24 225020
APO-GLICLAZIDE MR APOTEX INC Actual shortage 60MG Updated Report 2024-05-24 217481
APO-VALACYCLOVIR APOTEX INC Actual shortage 500MG Updated Report 2024-05-24 227031
APO-VALACYCLOVIR APOTEX INC Actual shortage 1000MG Updated Report 2024-05-24 227714
JAMP CANDESARTAN-HCT JAMP PHARMA CORPORATION Actual shortage 16MG 12.5MG Updated Report 2024-05-24 211765
JAMP CANDESARTAN-HCT JAMP PHARMA CORPORATION Actual shortage 12.5MG 16MG Updated Report 2024-05-24 218700
JAMP CANDESARTAN-HCT JAMP PHARMA CORPORATION Actual shortage 12.5MG 32MG Updated Report 2024-05-24 211768
JAMP CANDESARTAN-HCT JAMP PHARMA CORPORATION Actual shortage 12.5MG 32MG Updated Report 2024-05-24 211771
APO-VERAP TABLET 120MG APOTEX INC Resolved 120MG Updated Report 2024-05-24 225017
APO-VARENICLINE APOTEX INC Actual shortage 1MG Updated Report 2024-05-24 225764
APO-OLANZAPINE ODT APOTEX INC Resolved 20MG Updated Report 2024-05-24 225008
APO-MIRTAZAPINE APOTEX INC Resolved 30MG Updated Report 2024-05-24 225002
APO-MIRTAZAPINE APOTEX INC Resolved 45MG Updated Report 2024-05-24 226333
APO-MIDODRINE APOTEX INC Resolved 2.5MG Updated Report 2024-05-24 219162
APO-MIDODRINE APOTEX INC Resolved 5MG Updated Report 2024-05-24 217472
APO-ESOMEPRAZOLE APOTEX INC Actual shortage 20MG Updated Report 2024-05-24 227073
APO-DOXYCYCLINE MR APOTEX INC Resolved 40MG Updated Report 2024-05-24 225796

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
VITAMIN A ACID BAUSCH HEALTH, CANADA INC. Discontinued 0.01% Updated Report 2024-05-23 217835
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) SANDOZ CANADA INCORPORATED Discontinued 10000UNIT Updated Report 2024-05-18 228249
SANDOZ PRAVASTATIN TABLETS SANDOZ CANADA INCORPORATED Discontinued 20MG Updated Report 2024-05-18 228256
SANDOZ PRAVASTATIN TABLETS SANDOZ CANADA INCORPORATED Discontinued 40MG Updated Report 2024-05-18 228263
SANDOZ SENNA S SANDOZ CANADA INCORPORATED Discontinued 50MG 8.6MG Updated Report 2024-05-18 228268
SUPREFACT DEPOT 3 MONTHS CHEPLAPHARM ARZNEIMITTEL GMBH Discontinued 9.45MG Updated Report 2024-05-17 228166
ANANDRON CHEPLAPHARM ARZNEIMITTEL GMBH Discontinued 50MG Updated Report 2024-05-17 228155
FOSRENOL TAKEDA CANADA INC To be discontinued 1000MG New Report 2024-05-16 228184
FOSRENOL TAKEDA CANADA INC To be discontinued 750MG New Report 2024-05-16 228181
FOSRENOL TAKEDA CANADA INC To be discontinued 500MG New Report 2024-05-16 228178
SUPREFACT DEPOT 2 MONTHS CHEPLAPHARM ARZNEIMITTEL GMBH To be discontinued 6.3MG New Report 2024-05-16 228169
EYE STREAM ALCON CANADA INC Discontinued 0.03% 0.048% 0.075% 0.64% New Report 2024-05-15 228021
MYLAN-NITRO SUBLINGUAL SPRAY MYLAN PHARMACEUTICALS ULC Discontinued 0.4MG New Report 2024-05-08 227338
CHAMPIX PFIZER CANADA ULC Discontinued 1MG 0.5MG New Report 2024-05-03 227052
CHAMPIX PFIZER CANADA ULC Discontinued 1MG New Report 2024-05-03 227049
CHAMPIX PFIZER CANADA ULC Discontinued 0.5MG New Report 2024-05-03 227046
AUBAGIO SANOFI-AVENTIS CANADA INC To be discontinued 14MG New Report 2024-05-02 226847
SANDOZ OXYCODONE/ACETAMINOPHEN SANDOZ CANADA INCORPORATED Discontinued 325MG 5MG Updated Report 2024-05-02 226748
SANDOZ OXYCODONE/ACETAMINOPHEN SANDOZ CANADA INCORPORATED Discontinued 325MG 5MG Updated Report 2024-05-02 226753
HUMULIN R ELI LILLY CANADA INC To be discontinued 100UNIT New Report 2024-05-02 224344